ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 671,34
1,34%
Dow Jones
39 134,76
0,77%
DAX
18 254,18
1,03%
Brent Oil
85,005
0,37%
Bitcoin
64 955,67
-0,02%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Tourmaline Bio Inc (TRML)

  7. Tourmaline Bio Inc (TRML) Actualités

TRML Tourmaline Bio Inc

15,86
0,31 (1,99%)
Après les heures de négociation
Dernière mise à jour : 00:04:30
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Tourmaline Bio Inc TRML NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,31 1,99% 15,86 00:04:30
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
15,50 14,925 15,525 15,11 15,55
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
07/6/202422:04EDGAR2Form 8-K - Current report
07/6/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202413:10GLOBETourmaline Bio to Present at the Jefferies Global Healthcare..
16/5/202413:00GLOBETourmaline Bio Initiates Clinical Development of TOUR006 for..
13/5/202422:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202413:15EDGAR2Form 8-K - Current report
13/5/202413:00GLOBETourmaline Bio Reports First Quarter 2024 Financial Results..
02/4/202413:00GLOBEAvalo Therapeutics Appoints Biotech Leaders to Board of..
19/3/202412:00GLOBETourmaline Bio Reports Fourth Quarter and Full Year 2023..
27/2/202413:30GLOBETourmaline Bio to Present at Upcoming Investor Conferences
15/2/202403:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202402:51EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/2/202422:22EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/2/202414:00GLOBETourmaline Bio to Present at the Guggenheim Healthcare Talks..
29/1/202422:01GLOBETourmaline Bio Announces Closing of $172.5 Million Public..
26/1/202422:12EDGAR2Form 8-K - Current report
26/1/202422:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
25/1/202413:00GLOBETourmaline Bio Announces Pricing of Public Offering of..
25/1/202403:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
24/1/202423:10EDGAR2Form 8-K - Current report
24/1/202422:05GLOBETourmaline Bio Announces Proposed Public Offering of Common..
08/1/202415:19EDGAR2Form 8-K - Current report
08/1/202413:00GLOBETourmaline Bio Announces Expected Upcoming Key Milestones..
15/12/202322:00GLOBETourmaline Bio added to the NASDAQ Biotechnology Index
14/12/202314:27EDGAR2Form 8-K - Current report
14/12/202313:30GLOBETourmaline Bio Appoints Dr. Clay Siegall as Chairman of the..
30/11/202314:25EDGAR2Form 8-K - Current report
01/11/202313:00GLOBETourmaline Bio to Present at Upcoming Investor Conferences
24/10/202302:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202302:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202302:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202302:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202302:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202302:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202300:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/10/202323:37GLOBETourmaline Bio Announces Closing of Merger with Talaris..

Dernières Valeurs Consultées

NASDAQ
TRML
Tourmaline Bio
BIT
S27208
Societe Generale Effekten
NYSE
WBS.P.G
Webster Financia
LSE
ZN41
Ashtead Cap 33a
USOTC
SNNHF
Kingwell (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés